Accession Number: A1304040320 Order Number: G1234567 Reference Number: Patient: Sample Report Age: 51 Sex: Female 02/05/1962

4/3/13 4/4/13 4/5/13 7704464583 7704412237 7/24/13 Date of Birth:

Ordering Physician: John Doe MD 1234 Main St. Anywhere, GA 30096

Date Collected: Date Received: Report Date: Telephone: Fax: Reprinted: Comment:

0090 ION Profile

Ordering Physician: John Doe MD

Date Received:04/04/2013 Date Reported: 04/05/2013

A1304040320 Sample Report

Methodology: ION Exchange HPLC

Amino Acids 20 Profile - Plasma

Ranges: Ages 13 and over.

Essential Amino Acids

Limiting Amino Acids
Results mol/L
117 203

95% Reference Interval

1 2 3

Lysine Methionine Tryptophan

122
16

26

99 - 234

20
35

59

14 - 30

54
40

72

30 - 67

Branched Chain Amino Acids

4 5 6 Isoleucine Leucine Valine 43
80

137

33 - 89 68 - 161
240

84
143

L

140

43 64

123 - 282

Other Essential Amino Acids

7 8 9 Phenylalanine Histidine Threonine 57
48

72

39 - 74 41 - 82
151

53
76

48 96

83

63 - 181

Conditionally Essential Amino Acids

10 Arginine 11 Taurine 12 Glycine 13 Serine 62
31

73

37 - 114

54
162

348

26 - 100 136 - 430

115

241
66

104

57 - 133

Page 1

Ordering Physician:

Date Received:04/04/2013 Date Reported: 04/05/2013

A1304040320 Sample Report

Methodology: ION Exchange HPLC

John Doe MD

Amino Acids 20 Profile - Plasma

Ranges: Ages 13 and over.

Functional Categories
Vascular Function
14 Arginine 15 Taurine

Results mol/L
48 31 96 73

95% Reference Interval

62 54

37 - 114 26 - 100

Neurotransmitters and Precursors

16 Phenylalanine 17 Tyrosine 18 Tryptophan 19 Glutamic Acid 20 Taurine 57 57 54 41 54
43 38 35 29 31

64 70 59 95 73

39 - 74 29 - 80 30 - 67 23 - 136 26 - 100

Sulfur Amino Acids (Glutathione - related)

21 Methionine 22 Taurine 20 54
16 31

26 73

14 - 30 26 - 100

Urea Cycle and Ammonia Detoxification

23 Arginine 24 Citrulline 25 Ornithine 26 Glutamine 27 Asparagine 28 Aspartic Acid 62 27 73 556 47 6.2
48 20 32 397 30 4.8

96 38 81 585 49 9.7

37 - 114 15 - 44 23 - 109 338 - 630 26 - 56 4.2 - 12.5

Ratios
29 Phenyalanine/Tyrosine 30 Glutamic Acid/Glutamine 31 Tryptophan/LNAA* 1.00
0.06 1.44

0.21

<= 1.44 0.05 - 0.35

0.106

0.07
0.100

0.142 H

0.095 - 0.106

*Large neutral amino acids (Leu+Ile+Val+Phe+Tyr)

Page 2

Ordering Physician: John Doe MD

Date Received: 4/4/2013 Date Reported: 4/5/2013

A1304040320 Sample Report

Methodology: Competitive Immunoassay

Homocysteine Assay - Plasma

Results nmol/mL
4.0 10.0

95% Reference Interval

Homocysteine

10.2 H

3.0 - 14.0

Page 3

Ordering Physician: John Doe MD

Date Received: 4/4/2013 Date Reported: 4/5/2013

A1304040320 Sample Report

Nutrient & Toxic Elements Profile - Blood

Results

Methodology: Inductively Coupled Plasma /Mass Spectroscopy

95% Reference Interval

Nutrient Elements
Erythrocytes (packed cells)
3,055

1 Potassium 2 Magnesium 3 Calcium* Plasma

3,251 52 29

44

2,426 - 4,472

ppm ppm ppm

44

34 - 63 24 - 65

815

4 Zinc 5 Copper Whole Blood

770 L 1,325

929

643 - 1,594

ppb ppb

0.16

753 - 1,920

6 Selenium

0.21

0.13 - 0.32

ppm

Toxic Elements
Whole Blood
45

7 Aluminum 8 Arsenic 9 Cadmium 10 Lead 11 Mercury

13 <2.34 <0.39 9 6.0

5.1

<= 140 <= 13.7

0.60

ppb ppb ppb ppb ppb

18

<= 1.50

4.3

<= 36

<= 13.8

*Relevant to membrane permeability, not nutritional status. Toxic metals are flagged high when the result is above the 95% Reference Interval. Results for whole blood toxic elements that are within normal limits do not rule out metal accumulation in other tissues. This can be evaluated with urinary porphyrin or urine elements tests.

Page 4

Ordering Physician: John Doe MD

Date Received: 4/4/2013 Date Reported: 4/5/2013

A1304040320 Sample Report

CoEnzyme Q10 Plus Vitamins Profile - Serum

Ranges: Ages 13 and over. Results mg/L
0.64

Methodology: High Performance Liquid Chromatography

95% Reference Interval

2.16

1 Coenzyme Q10 2 alpha-Tocopherol 3 gamma-Tocopherol 4 Vitamin A 5 -Carotene

1.21
9.8

25.1

0.48 - 3.04

19.8
0.26

2.06

6.8 - 31.7 0.06 - 2.99

0.74

0.39
0.36

0.15 1.70

0.51 0.40

0.29 - 1.05 0.10 - 2.71

Lipid Peroxide Assay - Serum

Results nmol/mL

Methodology: High Performance Liquid Chromatography

1.72

6 Lipid Peroxides

0.70

<= 2.60

DNA/Oxidative Stress Marker Assay - Urine

Ranges: Ages 13 and over. Results ng/mg creatinine

Methodology: LC/Tandem Mass Spectroscopy, Colorimetric

5.3

7 8-Hydroxy-2-deoxyguanosine

3.5

<= 7.6
Methodology: LC/Tandem Mass Spectroscopy

Vitamin D Profile - Serum

Results ng/mL

Reference Interval
Sufficient

8 25-Hydroxyvitamin D

35.7
30

50 80 100

30.0 - 100.0
Optimal

9 25-Hydroxyvitamin D2 10 25-Hydroxyvitamin D3

1.0 34.7

Total 25-Hydroxyvitamin D is considered the best assessment of vitamin D status. The test reflects vitamin D from all sources (diet, supplements, and sun exposure). A 2011 Endocrine Society Clinical Practice Guideline suggested vitamin D deficiency be defined as < 20 ng/ml, insuffuciency as 21-29 ng/ml, and sufficiency as 30-100 ng/ml. The Vitamin D Council has proposed 50-80 ng/ml as optimal, and 100 ng/ml as an upper limit. 25-Hydroxyvitamin D3 is from sun exposure, vitamin D-rich foods, or vitamin D3 supplements. 25-Hydroxyvitamin D2 is only from fortified foods or supplements. 1. Holick MF, Binkley, NC, Bischoff-Ferrari, HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. July 2011, 96(7):1911-1930. 2. Vitamin D Council http://www.vitamindcouncil.org. Conversion factors: nmol/L = ng/mL x 2.5 | ng/mL = nmol/L x 0.4 * <DL = less than detection limit

Page 5

Ordering Physician: John Doe MD

Date Received: 4/4/2013 Date Reported: 4/5/2013

A1304040320 Sample Report

Fatty Acids Profile - Plasma

Ranges: Ages 13 and over. Results mol/L

Methodology: Capillary Gas Chromatography/Mass Spectrometry

95% Reference Interval

Polyunsaturated Omega-3
20

1 Alpha Linolenic (18:3n3) 2 Eicosapentaenoic (20:5n3) 3 Docosapentaenoic (22:5n3) 4 Docosahexaenoic (22:6n3)

22 5 L 8 L 24 L

17

13 - 80 5 - 210
16

59

11 - 50 31 - 213
930 1,669

Polyunsaturated Omega-6
5 Linoleic (18:2n6) 6 Gamma Linolenic (18:3n6) 7 Eicosadienoic (20:2n6) 8 Dihomogamma Linolenic (20:3n6) 9 Arachidonic (20:4n6) 10 Docosadienoic (22:2n6) 11 Docosatetraenoic (22:4n6) 476 L 7
6.4

7 33

821 - 2,032

15.3

5 - 46 5.2 - 22.5
102

7.0 16 L 150 L <0.23

34

201 451

27 - 140 158 - 521

0.9

<= 2.0
3.7 13.8

7.6

5.3

2.6 - 18.1

Polyunsaturated Omega-9
12 Mead (20:3n9) 1.3

1.2 6.1

<= 8.3

Monounsaturated
13 Myristoleic (14:1n5) 14 Palmitoleic (16:1n7) 15 Vaccenic (18:1n7) 16 Oleic (18:1n9) 17 11-Eicosenoic (20:1n9) 18 Nervonic (24:1n9) 2.6
40

155

0.8 - 9.7 30 - 256

93

44 55 696 6.2 <1.1 L

48

555 1,182

40 - 122 466 - 1,470

10.3

4.6

1.1 2.2

3.7 - 18.1 1.1 - 2.7

Page 6

Ordering Physician: John Doe MD

Date Received: 4/4/2013 Date Reported: 4/5/2013

A1304040320 Sample Report

Fatty Acids Profile - Plasma

Ranges: Ages 13 and over. Results mol/L

Methodology: Capillary Gas Chromatography/Mass Spectrometry

95% Reference Interval

Saturated
1.4 4.0

19 Capric (10:0) 20 Lauric (12:0) 21 Myristic (14:0) 22 Palmitic (16:0) 23 Stearic (18:0) 24 Arachidic (20:0) 25 Behenic (22:0) 26 Lignoceric (24:0) 27 Hexacosanoic (26:0)

1.7 6.4 34 1,073 379 0.9 L 0.7 L 0.95 <0.27

3.3 14.5

0.7 - 6.2 2.2 - 27.3

87

20

792 1,794

15 - 139 667 - 2,526

511

294

1.5 3.2

250 - 629 1.3 - 4.7

0.8 2.0

0.84 1.66

0.6 - 2.9 0.63 - 2.45

0.36

<= 0.43

Odd Chain
14.5

28 Pentadecanoic (15:0) 29 Heptadecanoic (17:0) 30 Nonadecanoic (19:0) 31 Heneicosanoic (21:0) 32 Tricosanoic (23:0)

3.7 7.2 <0.86

19.3

<= 20.6 <= 24.4

1.51

0.50

<= 1.89 <= 0.74

0.62

<0.38 <0.37
0.4

<= 0.78

Trans
33 Palmitelaidic (16:1n7t) 34 Total C:18 Trans <0.4
42

<= 1.8

14

30

<= 59

Ratios
35 LA/DGLA 36 EPA/DGLA 37 AA/EPA 38 Triene/Tetraene 30
0.24

20

11 - 46 0.07 - 5.98

0.31 30 H 0.009

0.016

1 - 57 <= 0.023

Page 7

Ordering Physician: John Doe MD

Date Received: 4/4/2013 Date Reported: 4/5/2013

A1304040320 Sample Report

Organix Comprehensive Profile - Urine

Ranges: Ages 13 and over. Results mcg/mg creatinine

Methodology: LC/Tandem Mass Spectroscopy, Colorimetric

95% Reference Interval

Nutrient Markers
Fatty Acid Metabolism
(Carnitine & B2)

1 Adipate 2 Suberate 3 Ethylmalonate

7.3 H 2.8 H 2.6

6.2 2.1

<= 11.1 <= 4.6 <= 6.3

3.6

Carbohydrate Metabolism
(B1, B3, Cr, Lipoic Acid, CoQ10)

4 Pyruvate 5 L-Lactate 6 -Hydroxybutyrate

(B comp., Q10, Amino acids, Mg)

1.6 5.4 <DL*

3.9 12.6 2.1

<= 6.4 1.6 - 57.1 <= 9.9

Energy Production (Citric Acid Cycle)

7 Citrate 8 Cis-Aconitate 9 Isocitrate 10 a-Ketoglutarate 11 Succinate 12 Fumarate 13 Malate 14 Hydroxymethylglutarate 334 44 90 6.9 19.6 H 0.86 H 0.8 3.5

601 51 98 19.0 11.6 0.59 1.4

56 - 987 18 - 78 39 - 143 <= 35.0

<= 20.9 <= 1.35 <= 3.1 <= 5.1

3.6

B-Complex Vitamin Markers

(B1, B2, B3, B5, B6, Biotin) 0.25

15 a-Ketoisovalerate 16 a-Ketoisocaproate 17 a-Keto--Methylvalerate 18 Xanthurenate 19 -Hydroxyisovalerate

0.16 0.23 <DL* 1.03 H 4.4

<= 0.49
0.34 0.38

<= 0.52 <= 1.10

0.34

<= 0.46 <= 11.5

7.6

Methylation Cofactor Markers

(B12, Folate)

20 Methylmalonate 21 Formiminoglutamate

0.4 0.1

1.7 1.2

<= 2.3 <= 2.2

Page 8

Ordering Physician: John Doe MD

Date Received: 4/4/2013 Date Reported: 4/5/2013

A1304040320 Sample Report

Organix Comprehensive Profile - Urine

Ranges: Ages 13 and over.
Results mcg/mg creatinine

Methodology: LC/Tandem Mass Spectroscopy, Colorimetric

95% Reference Interval

Cell Regulation Markers

Neurotransmitter Metabolism Markers
(Tyrosine, Tryptophan, B6, antioxidants)

22 Vanilmandelate 23 Homovanillate 24 5-Hydroxyindoleacetate 25 Kynurenate 26 Quinolinate 27 Picolinate

(Vitamin C and other antioxidants)

5.0 H 7.5 H 0.9 L 1.4 H 3.3 3.5

1.6 1.9

3.9 5.7 5.6 1.0

1.2 - 5.3 1.4 - 7.6 1.6 - 9.8 <= 1.5 <= 5.8 2.8 - 13.5

2.1

4.0 8.0

Oxidative Damage and Antioxidant Markers

28 p-Hydroxyphenyllactate 29 8-Hydroxy-2-deoxyguanosine 1.15 H 3.5
0.39

<= 0.66 <= 7.6

5.3

(Units for 8-Hydroxy-2-deoxyguanosine are ng/mg creatinine).

Toxicants and Detoxification

Detoxification Indicators
(Arg, NAC, Met, Mg and antioxidants)

30 2-Methylhippurate 31 Orotate 32 Glucarate 33 a-Hydroxybutyrate 34 Pyroglutamate 35 Sulfate

0.016 0.22 5.5 0.2 12 L 3,492 H

0.084 0.69 6.3 0.3

<= 0.192 <= 1.01 <= 10.7 <= 0.9

958

59 2,347

28 - 88

690 - 2,988

Page 9

Ordering Physician:

John Doe MD

Date Received: 4/4/2013 Date Reported: 4/5/2013

A1304040320 Sample Report

Organix Comprehensive Profile - Urine

Ranges: Ages 13 and over. Results mcg/mg creatinine

Methodology: LC/Tandem Mass Spectroscopy, Colorimetric

95% Reference Interval

Compounds of Bacterial or Yeast/Fungal Origin

Bacterial - general
0.6

36 Benzoate 37 Hippurate 38 Phenylacetate 39 Phenylpropionate 40 p-Hydroxybenzoate 41 p-Hydroxyphenylacetate 42 Indican 43 Tricarballylate

<DL* 551 H <DL* <DL* <DL* 52 H 60 0.44

548

<= 9.3

<= 1,070 <= 0.18 <= 0.06

0.11

1.1 19

<= 1.8

<= 34 <= 90 <= 1.41

64 0.73

L. acidophilus / general bacterial

44 D-Lactate 1.0
1.9

<= 4.3

Clostridial species
45 3,4-Dihydroxyphenylpropionate <DL*
36

<= 0.05

Yeast / Fungal
46 D-Arabinitol Creatinine = 159 mg/dL * <DL = less than detection limit ** >LIN = greater than linearity limit 56 H

<= 73

Page 10

ION Analyte Pattern Analysis

A1304040320 Sample Report

A multi-analyte report can provide greater insight about health risks and special nutrient needs. Patterns of abnormalities can reinforce the degree of significance indicated by a single measurement. Analytes from the various profiles in the ION report are combined below into categories associated with clinical/metabolic conditions. The categories included cover the most common areas of concern relevant to these profiles. Above each thermometer are listed the analytes used to calculate the degree of significance. An H or L appears when the patient result is in the fifth quintile (80%) of the population. An additional X next to an analyte indicates that the patient result is outside the 95% reference interval for that analyte. The thermometer advances to the right as the number and severity of relevant abnormalities increases. The longer the filled bar, the greater the degree of significance or likelihood that a health threat may exist in that category. The preceeding laboratory reports provide the detail upon which these thermometers are based.

Cardiovascular System
Arginine CoQ10 8-OHdG Homocysteine a-Tocopherol AA/EPA

H H

Calcium g-Tocopherol

Magnesium Lipid Peroxide

Low significance

Leucine CoQ10 Succinate FIGLU Phenylalanine Adipate

High significance

Fatigue
Isoleucine Magnesium AKG MeMalonate Valine

L H

Suberate

Malate

Xanthurenate X H

Low significance

Palmitic BHiVal Stearic AHB

High significance

Metabolic Syndrome (Syndrome X)

Magnesium BHB

Low significance

High significance

Mental/Emotional
Tryptophan DHA VMA Tyrosine Magnesium EPA FIGLU

X L H

Xanthurenate 5-HIA

X H X L

MeMalonate

Low significance

Page 11

High significance

ION Analyte Pattern Analysis

Intestinal Bacterial Metabolites
PhAc Indican PhProp Tricarb pOHBenz D-Lactate pOHPhAc

A1304040320

Sample Report

XH

3,4-DHPP

Low significance

H

High significance

Intestinal Yeasts / Fungal Metabolites

D-Arabinitol

Low significance

Histidine Methionine Valine Isoleucine Phenylalanine Selenium Leucine Threonine

High significance

Digestion/Absorption
Arginine Lysine Tryptophan

Low significance

Arsenic Palmitelaidic Isocitrate Glucarate Cadmium C18TrFa Quinolinate Lead

High significance

Toxic Exposure
Aluminum Mercury Cis-Aconitate Orotate Citrate 2-MeHipp

Low significance

High significance

Detoxification Impairment
Methionine Glutamine Glycine Pyroglutamate X L Serine Sulfate Taurine Benzoate

Low significance

High significance

Page 12

ION Analyte Pattern Analysis

Oxidative Stress/Antioxidant Insufficiency
Taurine a-Tocopherol Lipid Peroxide Selenium Vitamin A 8-OHdG Lead g-Tocopherol pOHPhLac Mercury

A1304040320

Sample Report

b-Carotene

X H

Sulfate

Low significance

CoQ10 Pyruvate Succinate Adipate L-Lactate Fumarate

High significance

Mitochondrial Functional Impairment

Magnesium Ethylmalonate BHB

H H

Suberate AHB Malate

Low significance

Histidine Methionine Valine Isoleucine Phenylalanine AKG

High significance

Amino Acid Insufficiency

Arginine Lysine Tryptophan Sulfate Leucine Threonine Succinate

AA LA

Low significance

XL XL
ALA GLA EPA DGLA

High significance

Essential Fatty Acid Insufficiency

L XL
DHA Palmitoleic

XL

Triene/Tetraene

Low significance

H H
Pentadeca Xanthurenate X H Heptadeca MeMalonate Nonadecanoic FIGLU

High significance

Disordered Methyl Group (Single carbon) Transfer

Homocysteine Tricosanoic Kynurenate

Low significance

Page 13

High significance

ION Analyte Pattern Analysis

Disordered Tryptophan Metabolism
Tryptophan Quinolinate Xanthurenate X H Indican 5-HIA

A1304040320

Sample Report

XL

Kynurenate

Low significance

High significance

Abbreviation 2-MeHipp 5-HIA 8-OhdG AA/EPA AHB aKbMeVal aKiCap aKiVal AKG ALA a-Tocopherol BHB BHiVal C18TrFa CoQ10 DGLA DHA 3,4-DHPP EPA

Analyte Name 2-Methylhippurate 5-Hydroxyindoleacetate 8-Hydroxy-2-deoxyguanosine Arachidonic (20:4n6)/Eicosapentaenoic (20:5n3) a-Hydroxybutyrate a-Keto--Methylvalerate a-Ketoisocaproate a-Ketoisovalerate a-Ketoglutarate Alpha Linolenic (18:3n3) alpha-Tocopherol -Hydroxybutyrate -Hydroxyisovalerate Total C:18 Trans Coenzyme Q10 Dihomogamma Linolenic (20:3n6) Docosahexanoic (22:6n3) 3,4-Dihydroxyphenylpropionate Eicosapentaenoic (20:5n3)

Abbreviation FIGLU g-Tocopherol GLA Heptadeca Hcys HVA HMG LA MeMalonate Pentadeca PhAc PhProp pHBenz pHPhAc pHPhLac Total C:18 Tricarb Triene/Tetraene VMA

Analyte Name Formiminoglutamate gamma-Tocopherol Gamma Linoleic (18:3n6) Heptadecanoic (17:0) Homocysteine Homovanillate Hydroxymethylglutarate Linoleic (18:2n6) Methylmalonate Pentadecanoic (15:0) Phenylacetate Phenylpropionate p-Hydroxybenzoate p-Hydroxyphenylacetate p-Hydroxyphenyllactate Total c:18 Trans Tricarballylate Mead/Arachidonic Ratio Vanilmandelate

Page 14

A1304040320 Sample Report

Supplement Recommendation Summary

With knowledge of a patient's full medical history and concerns, the ION Profile laboratory results may be used to help create an individually optimized nutritional support program. Based strictly on the results from this test, the summary table below shows estimates of nutrient doses that may help to normalize nutrient-dependent metabolic functions.

Customized Vitamin and Mineral Formulation

Nutrients listed in this section are normally contained in a multi-vitamin preparation. "Base" amounts may be used to ensure health even when no abnormalities are found. Customized preparations of the multi-vitamin/mineral formula shown below may be produced by compounding pharmacies. Daily Amounts Units Added

Base Vitamin A B-Carotene Vitamin C Vitamin D Vitamin E (Mixed Tocopherols) Vitamin K* Thiamin (B1) Riboflavin (B2) Niacin (B3) Pyridoxine (B6) Folic Acid (or 5-Methyl-THF) Vitamin B12 Biotin Pantothenic Acid (B5) Calcium Citrate Iodine* Magnesium Zinc Selenium Copper Manganese* Chromium Molybdenum* Boron* 2500 IU 5500 IU 250 mg 400 IU 100 IU 100 mcg 5 mg 5 mg 25 mg 15 mg 400 mcg 50 mcg 100 mcg 25 mg 500 mg 75 mcg 250 mg 15 mg 100 mcg 1 mg 5 mg 200 mcg 25 mcg 1 mg

2000 mg

400 IU

10 mg

100 mg 500 mcg 800 mcg 600 mcg

200 mg 15 mg 100 mcg

* Nutrients with an asterisk are not modified based on the ION test results.

MM03

Page 15

A1304040320 Sample Report

Other Items Indicated for Individual Supplementation

Various conditionally essential nutrients and other potentially beneficial interventions appear in this section only if relevant abnormalities are present. These ingredients are not included in the customized vitamin formula on the previous page. Amino acids listed on this page result from functional markers of individual amino acid insufficiency and do not reflect amino acids measured in plasma.

Item Potential to Benefit from Probiotics Antifungals Black Currant Oil Carnitine Coenzyme Q10 Fish Oil Need for Other Antioxidants

Amount Low As needed 4 gm 800 mg 60 mg 6 gm Moderate

Page 16

Ordering Physician: John Doe MD

A1304040320 Sample Report

Customized Free-Form Amino Acids

The table below shows a customized amino acid formula based on the results of your laboratory profile. The formula is optimized by adding amounts shown in the Grams Added column according to the relative positions of results found. Directions: Adults mix 1 and 1/2 measuring teaspoon (5g) in juice or water 2 times daily between meals as a dietary supplement, or as directed by a health care provider. Children under 12 years old: 3/4 teaspoon 1-2 times daily between meals. Children under 5 years old: Use 1/4 teaspoon, 1-3 times daily; adjust for body weight. Grams Added % of Formula Active mg/day

L-Arginine HCl (80% active) L-Histidine HCl (74% active) L-Isoleucine L-Leucine L-Lysine HCl (80% active) L-Methionine L-Phenylalanine Taurine L-Threonine L-Tryptophan L-Valine Pyridoxal-5-phosphate Alpha-ketoglutaric acid Total grams added Base Formula amount Total Weight

2 1 3 4 5 0 0 0 3 0 6 0 0 24 276 300 0

10.46 11.70 8.83 12.08 11.46 6.41 10.75 0.00 7.74 1.84 11.41 0.27 7.69

836 866 883 1,208 916 641 1,075 0 774 184 1,141 25 707

L-5-Hydroxytryptophan

0.61

37

This formula is intended to optimize essential and conditionally essential amino acid intake. Other non-essential amino acids can be produced in human tissues. Pyridoxal-5-phosphate (an active form of vitamin B6) and alpha-ketoglutaric acid are key factors needed for the body's utilization of amino acids. The formula may be ordered as a powder that dissolves easily in beverages or may be added to foods such as applesauce. Other forms of supplemental dietary protein or amino acids may need to be restricted while using your customized formula. If enhanced energy levels prevent sleep, avoid bedtime use.
This formula is provided as a starting point that may guide decisions about medical treatment based on the test results. It is derived only from the laboratory results included in this report. Final recommendations should be based on consideration of the patient's medical history and current clinical condition.

In addition to the above customized amino acid formula, this patient may benefit from further use of single amino acids, as evidenced by profiles other than plasma amino acids. See the category, "Other Indicated Nutrients" on your Supplement Recommendation Summary Page.

Page 17